The specialty chemical industry is on the cusp of a turnaround, with projections indicating a robust 10–11% sequential growth in revenues for the January–March quarter (Q4 FY25). This marks a significant recovery after a challenging October–December quarter (Q3), which saw a 9% decline in revenues due to weak global demand and elevated inventory levels.

Experts attribute this positive shift to stabilizing price levels, easing pressure from Chinese suppliers, and early signs of demand recovery in key markets. These factors are expected to neutralize the sales slump that has persisted over the past few quarters.

The specialty chemical sector, critical for industries such as agrochemicals, pharmaceuticals, and polymers, had been grappling with high inventory levels and sluggish offtake. However, as inventory destocking phases out and global demand shows signs of revival, companies are optimistic about improved margins and revenue growth.

Industry leaders are also focusing on diversifying their supply chains, leveraging advanced technologies, and exploring new markets to mitigate the lingering effects of global economic uncertainty. This strategic pivot is expected to position the specialty chemical sector for sustainable growth in the upcoming quarters.

The Q4 results will be a crucial indicator of whether the industry has successfully navigated the headwinds and is on track for long-term stability.

4o